Jr. Robert M. Whelan, Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jr. Robert M. Whelan,.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jr. Robert M. Whelan,. Jr. Robert M. Whelan, is Director in ASPEN TECHNOLOGY INC /DE/ ($AZPN) and Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in Annovis Bio, Inc. ($ANVS).
Latest Insider Trading Transactions of Jr. Robert M. Whelan,
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANVS, ARIA, AZPN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | M | 130.51 | 1,474 | 192,372 | 0 | |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | M | 133.20 | 1,444 | 192,341 | 0 | |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | M | 15.50 | 6,048 | 93,744 | 0 | |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 141.06 | 252 | 35,547 | 2,745 | 3 K to 2.7 K (-8.41 %) |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 140.46 | 3,255 | 457,197 | 2,997 | 6.3 K to 3 K (-52.06 %) |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 139.49 | 5,089 | 709,865 | 6,252 | 11.3 K to 6.3 K (-44.87 %) |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 138.92 | 370 | 51,400 | 11,341 | 11.7 K to 11.3 K (-3.16 %) |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Buy | M | 130.51 | 1,474 | 192,372 | 20,677 | 19.2 K to 20.7 K (+7.68 %) |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Buy | M | 133.20 | 1,444 | 192,341 | 19,203 | 17.8 K to 19.2 K (+8.13 %) |
| May 28 2021 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Buy | M | 15.50 | 6,048 | 93,744 | 17,759 | 11.7 K to 17.8 K (+51.64 %) |
| Dec 30 2020 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 130.51 | 1,474 | 192,372 | 1,474 | |
| Dec 30 2020 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 747 | 0 | 11,711 | 11 K to 11.7 K (+6.81 %) |
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | C | 0.00 | 11,176 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | C | 0.00 | 83,333 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | C | 4.80 | 11,176 | 53,645 | 95,700 | 84.5 K to 95.7 K (+13.22 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | C | 0.00 | 59,524 | 0 | 84,524 | 25 K to 84.5 K (+238.10 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | P | 6.00 | 25,000 | 150,000 | 25,000 | 0 to 25 K |
| Sep 05 2019 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 133.20 | 1,444 | 192,341 | 1,444 | |
| Sep 05 2019 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 732 | 0 | 10,964 | 10.2 K to 11 K (+7.15 %) |
| Sep 05 2019 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 133.20 | 1,444 | 192,341 | 1,444 | |
| Sep 05 2019 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 732 | 0 | 10,964 | 10.2 K to 11 K (+7.15 %) |
| Feb 05 2019 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 96.86 | 1,250 | 121,075 | 10,232 | 11.5 K to 10.2 K (-10.89 %) |
| Sep 06 2018 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 115.36 | 1,605 | 185,153 | 1,605 | |
| Sep 06 2018 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 845 | 0 | 11,482 | 10.6 K to 11.5 K (+7.94 %) |
| Aug 22 2018 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 107.76 | 1,250 | 134,705 | 10,637 | 11.9 K to 10.6 K (-10.52 %) |
| May 02 2018 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 88.03 | 1,500 | 132,045 | 11,887 | 13.4 K to 11.9 K (-11.20 %) |
| Feb 14 2018 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 72.30 | 1,772 | 128,107 | 13,387 | 15.2 K to 13.4 K (-11.69 %) |
| Feb 14 2018 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 72.21 | 400 | 28,884 | 15,159 | 15.6 K to 15.2 K (-2.57 %) |
| Nov 07 2017 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | M | 14.38 | 14,000 | 201,320 | 0 | |
| Nov 07 2017 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 66.01 | 10,000 | 660,100 | 15,559 | 25.6 K to 15.6 K (-39.13 %) |
| Nov 07 2017 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Buy | M | 14.38 | 14,000 | 201,320 | 25,559 | 11.6 K to 25.6 K (+121.12 %) |
| Sep 06 2017 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 63.25 | 2,823 | 178,555 | 2,823 | |
| Sep 06 2017 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 1,542 | 0 | 11,559 | 10 K to 11.6 K (+15.39 %) |
| Feb 09 2017 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 54.21 | 700 | 37,948 | 10,017 | 10.7 K to 10 K (-6.53 %) |
| Nov 07 2016 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 48.34 | 2,000 | 96,680 | 10,717 | 12.7 K to 10.7 K (-15.73 %) |
| Sep 06 2016 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 45.46 | 3,666 | 166,656 | 3,666 | |
| Sep 06 2016 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 2,145 | 0 | 12,717 | 10.6 K to 12.7 K (+20.29 %) |
| May 09 2016 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Sell | S | 37.63 | 4,041 | 152,056 | 10,572 | 14.6 K to 10.6 K (-27.65 %) |
| Aug 05 2015 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 44.38 | 3,307 | 146,765 | 3,307 | |
| Aug 05 2015 | AZPN | ASPEN TECHNOLOGY I ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 1,999 | 0 | 14,613 | 12.6 K to 14.6 K (+15.85 %) |
| Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 7.39 | 25,000 | 184,750 | 25,000 | |
| Feb 04 2014 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 12,500 | 0 | 44,859 | 32.4 K to 44.9 K (+38.63 %) |
| Feb 04 2013 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 14,000 | 0 | 32,359 | 18.4 K to 32.4 K (+76.26 %) |
| Dec 27 2012 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Gift | G | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
| Dec 27 2012 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Gift | G | 0.00 | 35,000 | 0 | 18,359 | 53.4 K to 18.4 K (-65.59 %) |
| Jan 31 2012 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 18,359 | 0 | 53,359 | 35 K to 53.4 K (+52.45 %) |
| Feb 01 2011 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 20,000 | 0 | 35,000 | 15 K to 35 K (+133.33 %) |
| Apr 21 2010 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Option Exercise | A | 3.82 | 25,000 | 95,500 | 25,000 | |
| Apr 21 2010 | ARIA | ARIAD PHARMACEUTIC ... | Whelan, Jr. Robert M. | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Page: 1